SCHEMBL9334807

SCHEMBL9334807

CN=C(NC#N)NCCSCc1csc(NC=NN)n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.66
▸ CYP2D6 P10635 3/20 0.66
▸ HRH2 P25021 2/20 0.66
▸ MAPT P10636 1/20 0.66
▸ LMNA P02545 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ SLC22A2 O15244 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ ATP4A P20648 1/20 0.48
▸ APEX1 P27695 1/20 0.48
▸ PDE4A P27815 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ ATP4B P51164 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ SLC47A2 Q86VL8 1/20 0.48
▸ SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tiotidine SCHEMBL9334796 0.84 CYP3A4 (0.69) CYP3A4CYP2D6HRH2MAPTLMNA
Tiotidine SCHEMBL9334786 0.84 CYP3A4 (0.69) CYP3A4CYP2D6HRH2MAPTLMNA
Tiotidine SCHEMBL29395931 0.84 CYP3A4 (0.69) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL4606225 0.84 HRH4 (0.47) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11360309 0.83 CYP3A4 (0.74) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11357836 0.82 CYP3A4 (0.72) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11364135 0.82 CYP3A4 (0.72) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11357832 0.82 CYP3A4 (0.72) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11373962 0.82 CYP3A4 (0.72) CYP3A4CYP2D6HRH2MAPTLMNA
SCHEMBL11353503 0.81 CYP3A4 (0.70) CYP3A4CYP2D6HRH2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5364616-A Use of H-2 antagonists for treatment of gingivitis THE PROCTER & GAMBLE COMPANY (US) 1994-11-15 — — US disclosed
Send feedback